Schedule 13G ownership disclosure

APRICUS BIOSCIENCES, INC.

Security class unavailable

Event date: 2016-09-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-733233
Form type
SC 13G
Filer
SEELOS THERAPEUTICS, INC.
CIK
CIK 1017491
Filed
Oct 07, 2016
Reporting period
Sep 28, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub